Open AccessAn Economic Evaluation of Sunitinib Versus Pazopanib As First Line Treatment of Metastatic Renal Cell Carcinoma
Author(s) -
K.A.R. Ku Nurhasni,
Junainah Sabirin,
Sharifa Ezat Wan Puteh,
Maznah Dahlui
Publication year - 2018
Publication title -
journal of global oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.002
H-Index - 17
ISSN - 2378-9506
DOI - 10.1200/jgo.18.13100
Subject(s) - pazopanib , sunitinib , medicine , renal cell carcinoma , oncology , urology